Role of the rdxA and frxA genes in oxygen-dependent metronidazole resistance of Helicobacter pylori

Journal of Medical Microbiology

Volumn 53, Issue 11, 2004, Pages 1123-1128

  Gerrits, Monique M ^a   Van Der Wouden, Egbert Jan ^b   Bax, Dorine A ^a   Van Zwet, Anton A ^c   Van Vliet, Arnoud H M ^a   De Jong, Albertine ^c   Kusters, Johannes G ^a   Thijs, Jaap C ^b   Kuipers, Ernst J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Bethesda Hospital   (Netherlands)

^c Public Health Service of Groningen   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; FRXA PROTEIN; GENE PRODUCT; METRONIDAZOLE; OXIDOREDUCTASE; OXYGEN; RDXA PROTEIN; TETRACYCLINE; UNCLASSIFIED DRUG;

ANAEROBIC GROWTH; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CELL VIABILITY; DRUG ACTIVATION; FRXA GENE; GENE INACTIVATION; GENE MUTATION; HELICOBACTER PYLORI; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OXYGEN TENSION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RDXA GENE; STOMACH; TREATMENT OUTCOME;

AMOXICILLIN; ANAEROBIOSIS; ANTI-INFECTIVE AGENTS; BACTERIAL PROTEINS; CHLORAMPHENICOL; CLARITHROMYCIN; COLONY COUNT, MICROBIAL; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FMN REDUCTASE; GENE DELETION; GENES, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; NITROREDUCTASES; SEQUENCE ANALYSIS, DNA; TETRACYCLINE;

EID: 11144240220     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.45701-0     Document Type: Article

References (38)

1. Akopyanz, N., Bukanov, N. O., Westblom, T. U. & Berg, D. E. (1992). PCR-based RFLP analysis of DNA sequence diversity in the gastric pathogen Helicobacter pylori. Nucleic Acids Res 20, 6221-6225,
2. Bereswill, S., Krainick, C., Stahler, F., Herrmann, L. & Kist, M. (2003). Analysis of the rdxA gene in high-level metronidazole-resistant clinical isolates confirms a limited use of rdxA mutations as a marker for prediction of metronidazole resistance in Helicobacter pylori, FEMS Immunol Med Microbiol 36, 193-198.
3. Blaser, M. J. & Berg, D. E. (2001). Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest 107, 767-773.
4. Cederbrant, G., Kahlmeter, G. & Ljungh, A. (1992). Proposed mechanism for metronidazole resistance in Helicobacter pylori. J Antimicrob Chemother 29, 115-120.
5. Chisholm, S. A. & Owen, R. J. (2004). Frameshift mutations in frxA occur frequently and do not provide a reliable marker for metronidazole resistance in UK isolates of Helicobacter pylori. J Med Microbiol 53, 135-140.
6. Debets-Ossenkopp, Y. J., Brinkman, A. B., Kuipers, E. J., Vandenbroucke-Grauls, C. M. & Kusters, J. G. (1998). Explaining the bias in the 23S rRNA gene mutations associated with clarithromycin resistance in clinical isolates of Helicobacter pylori. Antimicrob Agents Chemother 42, 2749-2751.
7. Debets-Ossenkopp, Y. J., Pot, R. G., van Westerloo, D. J., Goodwin, A., Vandenbroucke-Grauls, C. M., Berg, D. E., Hoffman, P. S. & Kusters, J. G. (1999a). Insertion of mini-IS605 and deletion of adjacent sequences in the nitroreductase (rdxA) gene cause metronidazole resistance in Helicobacter pylori NCTC11637. Antimicrob Agents Chemother 43, 2657-2662.
8. Debets-Ossenkopp, Y. J., Herscheid, A. J., Pot, R. G., Kuipers, E. J., Kusters, J. G. & Vandenbroucke-Grauls, C. M. (1999b). Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands. J Antimicrob Chemother 43, 511-515.
9. Edwards, D. I. (1986). Reduction of nitroimidazoles in vitro and DNA damage. Biochem Pharmacol 35, 53-58.
10. Falsafi, T., Mobasheri, F., Nariman, F. & Najafi, M. (2004). Susceptibilities to different antibiotics of Helicobacter pylori strains isolated from patients at the pediatric medical center of Tehran, Iran. J Clin Microbiol 42, 387-389.
11. Gerrits, M. M., Schuijffel, D., van Zwet, A. A., Kuipers, E. J., Vandenbroucke-Grauls, C. M. & Kusters, J. G. (2002a). Alterations in penicillin-binding protein 1A confer resistance to β-lactam antibiotics in Helicobacter pylori. Antimicrob Agents Chemother 46, 2229-2233.
12. Gerrits, M. M., de Zoete, M. R., Arents, N. L., Kuipers, E. J. & Kusters, J. G. (2002b). 16S rRNA mutation-mediated tetracycline resistance in Helicobacter pylori. Antimicrob Agents Chemother 46, 2996-3000.
13. Glupczynski, Y., Megraud, F., Lopez-Brea, M. & Andersen, L. P. (2001). European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 20, 820-823.
14. Goodwin, A., Kersulyte, D., Sisson, G., Veldhuyzen van Zanten, S. J., Berg, D. E. & Hoffman, P. S. (1998). Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase. Mol Microbiol 28, 383-393.
15. Jenks, P. J. & Edwards, D. I. (2002). Metronidazole resistance in Helicobacter pylori. Int J Antimicrob Agents 19, 1-7.
16. Jenks, P. J., Labigne, A. & Ferrero, R. L. (1999a). Exposure to metronidazole in vivo readily induces resistance in Helicobacter pylori and reduces the efficacy of eradication therapy in mice. Antimicrob Agents Chemother 43, 777-781.
17. Jenks, P. J., Ferrero, R. L. & Labigne, A. (1999b). The role of the rdxA gene in the evolution of metronidazole resistance in Helicobacter pylori. J Antimicrob Chemother 43, 753-758.
18. Jeong, J. Y., Mukhopadhyay, A. K., Dailidiene, D. & 20 other authors (2000). Sequential inactivation of rdxA (HP0954) and frxA (HP0642) nitroreductase genes causes moderate and high-level metronidazole resistance in Helicobacter pylori. J Bacteriol 182, 5082-5090.
19. Kaihovaara, P., Hook-Nikanne, J., Uusi-Oukari, M., Kosunen, T. U. & Salaspuro, M. (1998). Flavodoxin-dependent pyruvate oxidation, acetate production and metronidazole reduction by Helicobacter pylori. J Antimicrob Chemother 41, 171-177.
20. Kusters, J. G., Gerrits, M. M., Van Strijp, J. A. & Vandenbroucke-Grauls, C. M. (1997). Coccoid forms of Helicobacter pylori are the morphologic manifestation of cell death. Infect Immun 65, 3672-3679.
21. Kwon, D. H., El-Zaatari, F. A., Kato, M., Osato, M. S., Reddy, R., Yamaoka, Y. & Graham, D. Y. (2000a). Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori. Antimicrob Agents Chemother 44, 2133-2142.
22. Kwon, D. H., Kato, M., El-Zaatari, F. A., Osato, M. S. & Graham, D. Y. (2000b). Frame-shift mutations in NAD(P)H flavin oxidoreductase encoding gene (FrxA) from metronidazole resistant Helicobacter pylori ATCC43504 and its involvement in metronidazole resistance. FEMS Microbiol Lett 188, 197-202.
23. Kwon, D. H., Hulten, K., Kato, M., Kim, J. J., Lee, M., El-Zaatari, F. A., Osato, M. S. & Graham, D. Y. (2001). DNA sequence analysis of rdxA and frxA from 12 pairs of metronidazole-sensitive and -resistant clinical Helicobacter pylori isolates. Antimicrob Agents Chemother 45, 2609-2615.
24. Lacey, S. L, Moss, S. F. & Taylor, G. W. (1993). Metronidazole uptake by sensitive and resistant isolates of Helicobacter pylori. J Antimicrob Chemother 32, 393-400.
25. Loffeld, R. J. & Fijen, C. A. (2003). Antibiotic resistance of Helicobacter pylori: a cross-sectional study in consecutive patients, and relation to ethnicity. Clin Microbiol Infect 9, 600-604.
26. Lopez-Brea, M., Martinez, M. J., Domingo, D. & Alarcon, T. (2001). A 9 year study of clarithromycin and metronidazole resistance in Helicobacter pylori from Spanish children. J Antimicrob Chemother 48, 295-297.
27. Malfertheiner, P., Megraud, F., O'Morain, C., Hungin, A. P., Jones, R., Axon, A., Graham, D. Y. & Tytgat, G. (2002). Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 16, 167-180.
28. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory.
29. Sisson, G., Goodwin, A., Raudonikiene, A., Hughes, N. J., Mukhopadhyay, A. K., Berg, D. E. & Hoffman, P. S. (2002). Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori. Antimicrob Agents Chemother 46, 2116-2123.
30. Smith, M. A. & Edwards, D. I. (1995). Redox potential and oxygen concentration as factors in the susceptibility of Helicobacter pylori to nitroheterocyclic drugs. J Antimicrob Chemother 35, 751-764.
31. Smith, M. A. & Edwards, D. I. (1997). Oxygen scavenging, NADH oxidase and metronidazole resistance in Helicobacter pylori. J Antimicrob Chemother 39, 347-353.
32. Smith, M. A., Jorgensen, M. A., Mendz, G. L. & Hazell, S. L. (1998). Metronidazole resistance and microaerophily in Campylobacter species. Arch Microbiol 170, 279-284.
33. Sugiyama, T., Sakaki, N., Kozawa, H. & 8 other authors (2002). Sensitivity of biopsy site in evaluating regression of gastric atrophy after Helicobacter pylori eradication treatment. Aliment Pharmacol Ther 16 Suppl. 2, 187-190.
34. Tomb, J. F., White, O., Kerlavage, A. R. & 39 other authors (1997). The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388, 539-547.
35. Trieber, C. A. & Taylor, D. E. (2002). Mutations in the 16S rRNA genes of Helicobacter pylori mediate resistance to tetracycline. J Bacteriol 184, 2131-2140.
36. van der Hulst, R. W., Keller, J. J., Rauws, E. A. & Tytgat, G. N. (1996). Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter 1, 6-19.
37. van der Wouden, E. J., Thijs, J. C., van Zwet, A. A., Sluiter, W. J. & Kleibeuker, J. H. (1999). The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: a meta-analysis. Am J Gastroenterol 94, 1751-1759.
38. Wilhelmsen, I. & Berstad, A. (1994). Quality of life and relapse of duodenal ulcer before and after eradication of Helicobacter pylori. Scand J Gastroenterol 29, 874-879.